FdaApplication
NDA 208692
Identifiers
- fda_app_no: NDA208692
Properties
| Property | Value |
|---|---|
| applicant_name | EXELIXIS INC |
| application_type | NDA |
| approval_date | 2016-04-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABOMETYX | CABOZANTINIB S-MALATE | EQ 20MG BASE | TABLET;ORAL |
| CABOMETYX | CABOZANTINIB S-MALATE | EQ 40MG BASE | TABLET;ORAL |
| CABOMETYX | CABOZANTINIB S-MALATE | EQ 60MG BASE | TABLET;ORAL |
3 products